 Douglas Wilson
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Toxoplasma | 3 | 2010 | 49 | 0.650 |
Why?
| | Toxoplasmosis, Animal | 2 | 2010 | 8 | 0.600 |
Why?
| | Interleukin-12 | 2 | 2010 | 117 | 0.570 |
Why?
| | Tumor Microenvironment | 5 | 2026 | 735 | 0.420 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2025 | 917 | 0.410 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2022 | 264 | 0.300 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2025 | 389 | 0.260 |
Why?
| | Immunologic Memory | 1 | 2010 | 366 | 0.260 |
Why?
| | Receptors, Immunologic | 1 | 2008 | 206 | 0.250 |
Why?
| | Interferon-gamma | 1 | 2008 | 784 | 0.210 |
Why?
| | Immunoconjugates | 1 | 2026 | 137 | 0.210 |
Why?
| | Cell Differentiation | 2 | 2010 | 2050 | 0.200 |
Why?
| | Neoplasms | 3 | 2025 | 2884 | 0.190 |
Why?
| | T-Lymphocyte Subsets | 1 | 2025 | 415 | 0.190 |
Why?
| | Flow Cytometry | 1 | 2025 | 1173 | 0.170 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 241 | 0.150 |
Why?
| | Interleukin-23 Subunit p19 | 1 | 2018 | 6 | 0.140 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2018 | 19 | 0.140 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2017 | 5 | 0.130 |
Why?
| | Immunotherapy | 1 | 2022 | 657 | 0.130 |
Why?
| | Immunophenotyping | 2 | 2025 | 322 | 0.120 |
Why?
| | Colitis | 1 | 2018 | 280 | 0.110 |
Why?
| | Antigens, CD | 1 | 2018 | 555 | 0.110 |
Why?
| | Antibodies | 1 | 2017 | 403 | 0.110 |
Why?
| | Mice | 8 | 2026 | 18365 | 0.100 |
Why?
| | Single-Cell Analysis | 1 | 2017 | 359 | 0.100 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 676 | 0.090 |
Why?
| | Proteins | 1 | 2017 | 1022 | 0.090 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2010 | 11 | 0.080 |
Why?
| | Macrophages | 1 | 2018 | 1511 | 0.080 |
Why?
| | Antigens, Protozoan | 1 | 2010 | 32 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2026 | 3550 | 0.080 |
Why?
| | Mice, Mutant Strains | 1 | 2010 | 299 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2018 | 5997 | 0.070 |
Why?
| | Animals | 8 | 2026 | 38109 | 0.070 |
Why?
| | Vacuoles | 1 | 2009 | 38 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2018 | 3125 | 0.070 |
Why?
| | GTP Phosphohydrolases | 1 | 2009 | 93 | 0.070 |
Why?
| | Protozoan Vaccines | 1 | 2008 | 1 | 0.070 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 2008 | 5 | 0.070 |
Why?
| | L-Selectin | 1 | 2008 | 27 | 0.070 |
Why?
| | GTP-Binding Proteins | 1 | 2009 | 153 | 0.070 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2008 | 28 | 0.070 |
Why?
| | Receptors, Interleukin-7 | 1 | 2008 | 28 | 0.070 |
Why?
| | Lectins, C-Type | 1 | 2008 | 62 | 0.070 |
Why?
| | Epitopes | 1 | 2010 | 485 | 0.070 |
Why?
| | Macrophage Activation | 1 | 2009 | 193 | 0.070 |
Why?
| | Protozoan Proteins | 1 | 2008 | 93 | 0.070 |
Why?
| | Signal Transduction | 3 | 2010 | 5233 | 0.060 |
Why?
| | Down-Regulation | 1 | 2008 | 627 | 0.060 |
Why?
| | Trastuzumab | 1 | 2026 | 118 | 0.060 |
Why?
| | Camptothecin | 1 | 2026 | 140 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2025 | 1129 | 0.060 |
Why?
| | Oligopeptides | 1 | 2026 | 269 | 0.050 |
Why?
| | Sepsis | 1 | 2010 | 641 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 573 | 0.050 |
Why?
| | Response Evaluation Criteria in Solid Tumors | 1 | 2021 | 21 | 0.040 |
Why?
| | Apoptosis | 1 | 2010 | 2430 | 0.040 |
Why?
| | Maximum Tolerated Dose | 1 | 2021 | 212 | 0.040 |
Why?
| | Sequence Analysis, Protein | 1 | 2017 | 33 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2018 | 202 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 187 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2017 | 251 | 0.030 |
Why?
| | Mutation | 1 | 2008 | 4099 | 0.030 |
Why?
| | Interleukins | 1 | 2018 | 248 | 0.030 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2018 | 364 | 0.030 |
Why?
| | Interleukin-10 | 1 | 2018 | 310 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 395 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 442 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2018 | 499 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2022 | 1322 | 0.030 |
Why?
| | Humans | 6 | 2026 | 144957 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2017 | 1253 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2021 | 1524 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 1126 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2022 | 4569 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 4155 | 0.020 |
Why?
| | Caspase 9 | 1 | 2010 | 55 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2010 | 60 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2010 | 163 | 0.020 |
Why?
| | Alanine Transaminase | 1 | 2010 | 151 | 0.020 |
Why?
| | Cytosol | 1 | 2010 | 227 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2832 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 89 | 0.020 |
Why?
| | Protein Transport | 1 | 2010 | 441 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2009 | 162 | 0.020 |
Why?
| | Spleen | 1 | 2010 | 508 | 0.020 |
Why?
| | Virulence | 1 | 2009 | 280 | 0.020 |
Why?
| | Female | 2 | 2026 | 78376 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2185 | 0.010 |
Why?
| | Mitochondria | 1 | 2010 | 984 | 0.010 |
Why?
| | Cytokines | 1 | 2010 | 2065 | 0.010 |
Why?
| | Liver | 1 | 2010 | 1888 | 0.010 |
Why?
| | Inflammation | 1 | 2010 | 2880 | 0.010 |
Why?
| | Male | 1 | 2010 | 72406 | 0.000 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|